Rerun: BEL Explains Targeted Antibody Cancer Treatment Revolution

Rerun for Memorial Day from our April 22, 2016 program.

* Targeted Antibodies Cancer Treatment Revolution: In the latest exciting results for targeted antibodies cancer treatment, CBS News has now reported on a 35 terminally-ill, advanced-stage leukemia sufferers. The disease went into remission in 94%, or 33 of 35 patients! Dr. Michael Grossbard, New York University's Perlmutter Cancer Center leukemia specialist told CBS News, "Oncologists are reluctant to use the word extraordinary. But these [results] are extraordinary. These are really remarkable findings..." Real Science Radio host Bob Enyart turns to RSR's targeted-antibody expert, Jonathan Bartlett, who explains both the molecular biology behind this new treatment and the worldview implications ahead of it. Bartlett also discusses the impossibility that an evolutionist faces in trying to understand such a treatment and why so many scholars are fleeing Darwinism.

* May 2016 Update from the Daily MailAre we nearing a cure for cancer? Holy grail is 'closer than ever', oncologist claims quotes Dr Rebecca Kristeleit, of University College London Hospital, who reports that advances in a revolutionary treatment called immunotherapy [targeted antibodies] were now occurring at a rapid rate. Dr Kristeleit added: 'We are beginning to start thinking about using that word 'cure'... As an oncologist, it's not a word you would ever say. This is because we talk a lot about being 'in remission' - but 'cure' is the Holy Grail."

 


May 2016 Update
: This time its lung cancer! According to Britain's Daily Express, "Merchant seaman Simon Lamont-Brown, 50, was bedridden in a hospice and near death from lung cancer before he was given the breakthrough treatment. He said it was like a Lazarus effect "because I just rose from the dead". The drug has few side effects because it harnesses the body's own immune system to fight tumours. Nivolumab has had "remarkable" success fighting end-stage lung cancer in trials, experts say. It is also effective against other cancers." (Hear Bob discuss this on the May 23, 2016 BEL program.)